Measuring the burden and mortality of hospitalisation in Parkinson's disease: A cross-sectional analysis of the English Hospital Episodes Statistics database 2009-2013

Parkinsonism and Related Disorders

Volumn 21, Issue 5, 2015, Pages 449-454

  Low, Vincent ^a   Ben Shlomo, Yoav ^b   Coward, Elena ^a   Fletcher, Suzanne ^a   Walker, Richard ^c,d   Clarke, Carl E ^e,f  

^a UCB PHARMA   (Belgium)

^b UNIVERSITY OF BRISTOL   (United Kingdom)

^c NORTH TYNESIDE GENERAL HOSPITAL   (United Kingdom)

^d NEWCASTLE UNIVERSITY   (United Kingdom)

^e UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^f CITY HOSPITAL   (United Kingdom)

Author keywords

Health economics; Hospitalisation; Mortality; Parkinson's disease

Indexed keywords

ADULT; AGED; ARTICLE; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; EMERGENCY CARE; FEMALE; HEALTH CARE COST; HIP FRACTURE; HOSPITAL ADMISSION; HOSPITALIZATION; HUMAN; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MORTALITY; MOTOR DYSFUNCTION; PARKINSON DISEASE; PNEUMONIA; PRIORITY JOURNAL; UNITED KINGDOM; URINARY TRACT INFECTION; VERY ELDERLY; COST OF ILLNESS; ECONOMICS; ENGLAND; EPIDEMIOLOGY; FACTUAL DATABASE; HOSPITAL MORTALITY; MIDDLE AGED; RETROSPECTIVE STUDY; TRENDS;

ADULT; AGED; AGED, 80 AND OVER; COST OF ILLNESS; CROSS-SECTIONAL STUDIES; DATABASES, FACTUAL; ENGLAND; FEMALE; HOSPITAL MORTALITY; HOSPITALIZATION; HUMANS; MALE; MIDDLE AGED; PARKINSON DISEASE; RETROSPECTIVE STUDIES;

EID: 84924068381     PISSN: 13538020     EISSN: 18735126     Source Type: Journal    
DOI: 10.1016/j.parkreldis.2015.01.017     Document Type: Article

References (32)

1. Dorsey E.R., Constantinescu R., Thompson J.P., Biglan K.M., Holloway R.G., Kieburtz K., et al. Projected number of people with Parkinson disease in the most populous nations, 2005 through 2030. Neurology 2007, 68:384-386.
2. Arasalingam A., Clarke C.E. Reasons for Parkinson's disease admissions in a large inner city hospital. Park Relat Disord 2014, 20:237-238.
3. Klein C., Prokhorov T., Miniovitz A., Dobronevsky E., Rabey J. Admission of Parkinsonian patients to a neurological ward in a community hospital. JNeural Transm 2009, 116:1509-1512.
4. Temlett J.A., Thompson P.D. Reasons for admission to hospital for Parkinson's disease. Intern Med J 2006, 36:524-526.
5. Vossius C., Nilsen O.B., Larsen J.P. Parkinson's disease and hospital admissions: frequencies, diagnoses and costs. Acta Neurol Scand 2010, 121:38-43.
6. Woodford H., Walker R. Emergency hospital admissions in idiopathic Parkinson's disease. Mov Disord 2005, 20:1104-1108.
7. Lubomski M., Rushworth R.L., Tisch S. Hospitalisation and comorbidities in Parkinson's disease: a large Australian retrospective study. JNeurol Neurosurg Psychiatry 2015, 86(3):324-330.
8. Guttman M., Slaughter P.M., Theriault M.E., DeBoer D.P., Naylor C.D. Burden of parkinsonism: a population-based study. Mov Disord 2003, 18:313-319.
9. Health and social care information centre Hospital episodes statistics 2014.
10. Modern epidemiology 1998, Lippincott-Raven, Philadelphia. 2nd ed. K. Rothman, S. Greenland (Eds.).
11. Porter B., Macfarlane R., Unwin N., Walker R. The prevalence of Parkinson's disease in an area of north tyneside in the north-east of England. Neuroepidemiology 2006, 26:156-161.
12. Wickremaratchi M.M., Perera D., O'Loghlen Carl, Sastry D., Morgan E., Jones A., et al. Prevalence and age of onset of Parkinson's disease in cardiff: a community based cross sectional study and meta-analysis. JNeurol Neurosurg Psychiatry 2009, 80:805-807.
13. Findley L., Aujla M., Bain P.G., Baker M., Beech C., Bowman C., et al. Direct economic impact of Parkinson's disease: a research survey in the United Kingdom. Mov Disord 2003, 18:1139-1145.
14. Gerlach O.H., Winogrodzka A., Weber W.E. Clinical problems in the hospitalized Parkinson's disease patient: systematic review. Mov Disord 2011, 26:197-208.
15. Clarke C.E. Has drug therapy changed the natural history of Parkinson's disease?. JNeurol 2010, 257:S262-S267.
16. Snell K., Pennington S., Lee M., Walker R. The place of death in Parkinson's disease. Age Ageing 2009, 38:617-619.
17. Pouwels S., Bazelier M.T., de Boer A., Weber W.E., Neef C., Cooper C., et al. Risk of fracture in patients with Parkinson's disease. Osteoporos Int 2013, 24:2283-2290.
18. Walker R.W., Chaplin A., Hancock R.L., Rutherford R., Gray W.K. Hip fractures in people with idiopathic Parkinson's disease: incidence and outcomes. Mov Disord 2013, 28:334-340.
19. van den Bos F., Speelman A.D., Samson M., Munneke M., Bloem B.R., Verhaar H.J. Parkinson's disease and osteoporosis. Age Ageing 2013, 42:156-162.
20. Blackett H., Walker R., Wood B. Urinary dysfunction in Parkinson's disease: a review. Park Relat Disord 2009, 15:81-87.
21. Pennington S., Snell K., Lee M., Walker R. The cause of death in idiopathic Parkinson's disease. Park Relat Disord 2010, 16:434-437.
22. Huntley A., Lasserson D., Wye L., Morris R., Checkland K., England H., et al. Which features of primary care affect unscheduled secondary care use? A systematic review. BMJ Open 2014, 4:e004746.
23. Jarman B., Hurwitz B., Cook A. Parkinson's disease nurse specialists in primary care: a randomised controlled trial. Mov Disord 2000, 15(suppl 3):178.
24. Tomlinson C.L., Patel S., Meek C., Herd C.P., Clarke C.E., Stowe R., et al. Physiotherapy versus placebo or no intervention in Parkinson's disease. Cochrane Database Syst Rev 2013, 9:CD002817.
25. Rolinski M., Fox C., Maidment I., McShane R. Cholinesterase inhibitors for dementia with lewy bodies, Parkinson's disease dementia and cognitive impairment in Parkinson's disease. Cochrane Database Syst Rev 2012, 3:CD006504.
26. Herd C.P., Tomlinson C.L., Deane K.H., Brady M.C., Smith C.H., Sackley C.M., et al. Speech and language therapy versus placebo or no intervention for speech problems in Parkinson's disease. Cochrane Database Syst Rev 2012, 8:CD002812.
27. Barber N.D., Alldred D.P., Raynor D.K., Dickinson R., Garfield S., Jesson B., et al. Care homes' use of medicines study: prevalence, causes and potential harm of medication errors in care homes for older people. Qual Saf Health Care 2009, 18:341-346.
28. National Council for Palliative Care The end of life care strategy 2014, new ambitions, London.
29. Skelly R., Brown L., Fakis A., Kimber L., Downes C., Lindop F., et al. Does a specialised unit improve outcomes for hospitalised patients with Parkinson's disease. Park Relat Disord 2015 Jan 6, [Epub ahead of print]. 10.10.16/j.parkreldis.2014.12.029.
30. Burns E.M., Rigby E., Mamidanna R., Bottle A., Aylin P., Ziprin P., et al. Systematic review of discharge coding accuracy. JPublic Health (Oxf) 2012, 34:138-148.
31. Hernan M.A., Takkouche B., Caamano-Isorna F., Gestal-Otero J.J. Ameta-analysis of coffee drinking, cigarette smoking, and the risk of Parkinson's disease. Ann Neurol 2002, 52:276-284.
32. Law M.R., Hackshaw A.K. Ameta-analysis of cigarette smoking, bone mineral density and risk of hip fracture: recognition of a major effect. BMJ 1997, 315:841-846.